Zhigang Li

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun, Lin Shen, Manish A. Shah et al. · The Lancet · 2021 · 1.5K citations · Full text

Chemotherapy Versus Chemotherapy, Oncology, Esophageal Cancer +8

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Jun Liu, Yang Yang, Zhichao Liu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 256 citations · Full text

IQGAP1 Promotes Cell Motility and Invasion

Jennifer Mataraza, Michael W. Briggs, Zhigang Li et al. · Journal of Biological Chemistry · 2003 · 205 citations · Full text

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Hao Wang, Han Tang, Yong Fang et al. · JAMA Surgery · 2021 · 179 citations · Full text

Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma

Yang Yang, Bin Li, Jun Yi et al. · Annals of Surgery · 2021 · 173 citations

Surgical Oncology, Esophageal Cancer, Open Procedure +16